FDA Drug Recalls

Recalls / Class II

Class IID-1013-2023

Product

oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-8069-1

Affected lot / code info
Lot: 36-241803, 36-241804, Exp. 7/21/2023; 36-243836, Exp. 7/31/2023; 36-246645, Exp. 8/3/2023; 36-246729, Exp. 8/6/2023; 36-248976, Exp. 8/16/2023; 36-249502, Exp. 8/17/2023; 36-252215, 8/31/2023; 36-255872, 36-255875, Exp. 9/10/2023

Why it was recalled

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2200 S 43rd Ave, N/A, Phoenix, Arizona 85043-3909

Distribution

Quantity
2692 bags
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-07-14
FDA classified
2023-08-01
Posted by FDA
2023-08-09
Terminated
2025-03-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1013-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.